Status:
COMPLETED
Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort
Lead Sponsor:
Tourcoing Hospital
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
HIV infection requires lifelong continuous antiretroviral (ARV) treatment. The efficacy of current ARV treatments makes it possible to propose strategies for reducing the cumulative exposure to ARVs, ...
Eligibility Criteria
Inclusion
- hiv patient
- viral load \< 50copies/ml
- patient treated with dual therapy
- patients with hospital follow-up between 2011 and 2023
Exclusion
- adults under legal protection
- underage
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
580 Patients enrolled
Trial Details
Trial ID
NCT06107140
Start Date
January 1 2011
End Date
May 1 2023
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier DRON
Tourcoing, France, 59208